In-stent Neoatherosclerosis: a New Problem or an Opportunity to Rethink the Treatment of Coronary Disease?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Thrane P, Olesen K, Thim T, Gyldenkerne C, Mortensen M, Kristensen S
. Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2023; 82(10):999-1010.
DOI: 10.1016/j.jacc.2023.06.025.
View
2.
Madhavan M, Kirtane A, Redfors B, Genereux P, Ben-Yehuda O, Palmerini T
. Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention. J Am Coll Cardiol. 2020; 75(6):590-604.
DOI: 10.1016/j.jacc.2019.11.058.
View
3.
Yamamoto F, Natsuaki M, Kuramitsu S, Ohya M, Otake H, Horie K
. Outcomes of Drug-Eluting Stent Thrombosis After Treatment for Acute Versus Chronic Coronary Syndrome. JACC Cardiovasc Interv. 2021; 14(10):1082-1090.
DOI: 10.1016/j.jcin.2021.03.051.
View
4.
Lazar F, Onea H, Olinic D, Cortese B
. A 2024 scientific update on the clinical performance of drug-coated balloons. AsiaIntervention. 2024; 10(1):15-25.
PMC: 10900242.
DOI: 10.4244/AIJ-D-23-00010.
View
5.
Camacho X, Nedkoff L, Wright F, Nghiem N, Buajitti E, Goldacre R
. Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality: an international comparative study of 1·95 million events in 80·4 million people in four countries. Lancet Public Health. 2022; 7(3):e229-e239.
DOI: 10.1016/S2468-2667(22)00006-8.
View